List of Outpatient Treatments under Medisave

Transcription

1 List of Outpatient Treatments under Medisave Type of Outpatient Treatment Renal Dialysis Medisave use for renal dialysis is only allowed from the patient's own Medisave account. Note: The patient may apply touse an immediate family member s Medisave subject to meeting eligibility conditions and will be assessed on individual case basis. The immediate family member must be the: 1. spouse 2. parent 3. grandparent who is a Singapore Citizen or Permanent Resident, or 4. child of the patient aged above 18 years old. Withdrawal Limit $450 per month per patient To be eligible, the immediate family member must also: (i) be an active Medisave contributor, (ii) have sufficient Medisave balances to meet his own needs as well as the patient's withdrawal for renal dialysis expenses. The sufficiency of your Medisave balance will depend on factors such as your Basic Healthcare Sum. You may submit an application online via e- Concierge request - Healthcare (Application to use Medisave for Immediate Family's Renal Dialysis). Please login using your SingPass under my cpf Online Services My Requests and select Other CPF Matters Applicant will be informed on the outcome of the application once it has been processed. Chemotherapy* Radiotherapy* : - External radiotherapy - Brachytherapy with external radiotherapy - Brachytherapy without external radiotherapy - Superficial X-ray - Stereotactic radiotherapy Assisted Conception Procedure (for female patients only) Note: Only the Medisave of the patient and her spouse can be used. $1,200 per month per patient $80 per treatment $300 per treatment $360 per treatment $30 per treatment $2,800 per treatment The withdrawal limits are 1st withdrawal - $6,000 2nd withdrawal - $5,000 3rd and subsequent withdrawal - $4,000 Up to $15,000 per patient per lifetime

2 Approved Drugs for HIV/AIDS $550 per month per patient Note : Only the patient's Medisave can be used. If the patient is aged 18 years old or below, the Medisave of the patient's parents may be used. Hyperbaric Oxygen Therapy Desferrioxamine Drug and Blood Transfusion for Thalassaemia* Intravenous Antibiotic Infusion* at : (1) KK Women's and Children's Hospital (2) National University Hospital (3) Singapore General Hospital (4) Tan Tock Seng Hospital Rental of Devices for Long-Term Oxygen Therapy and Infant Continuous Positive Airway Pressure Therapy* Immunosuppressant Drugs for Organ Transplant* MRI, CT scans and diagnostics** related to neoplasm treatment $100 per treatment $350 per month $600 per weekly cycle, up to a maximum of $2,400 per year. $75 per month $300 per month $600 per patient per year **Other diagnostics used in cancer treatments include blood tests, mammographs/ mammogram, ultrasounds, X-rays and PET which may be performed for pretreatment, evaluation during treatment and posttreatment follow-up. Outpatient Scans # $300 per patient per year # Excludes scans already covered under Medisave limits for specific treatments (e.g. cancer, pre-natal check-ups and screening mammograms) as existing withdrawal limits apply Home Palliative Care/Day Hospice Care $2,500 per patient s lifetime (Both Home Palliative Care and Day Hospice Care share the same lifetime limit. The lifetime limit will not apply if the patient is diagnosed with terminal cancer or end stage organ failure and the medical bill is paid using the patient s own Medisave)

3 Chronic Diseases 1. Diabetes 2. Hypertension 3. Lipid disorders 4. Stroke 5. Asthma 6. Chronic Obstructive Pulmonary Disease (COPD) 7. Schizophrenia 8. Major Depression 9. Dementia 10. Bipolar Disorder 11. Osteoarthritis 12. Benign Prostatic Hyperplasia 13. Anxiety 14. Parkinson s Disease 15. Nephrosis/Nephritis 16. Epilepsy 17. Osteoporosis 18. Psoriasis 19. Rheumatoid Arthritis $400 per Medisave Account holder per year Approved Vaccinations 1. Hepatitis B 2. Pneumococcal (PCV13) (for patients below the age of six years old) 3. Human Papillomavirus (HPV) (for female patients between the ages of 9 to 26) 4. 5-in-1 combination vaccination covering Diphtheria, Pertussis, Tetanus, Haemophilus Influenzae type b, Inactivated Poliomyelitis 5. 6-in-1 combination vaccination covering Diphtheria, Pertussis, Tetanus, Haemophilus Influenzae type b, Inactivated Poliomyelitis and Hepatitis B vaccinations 6. Diphtheria, Tetanus and acellular Pertussis (DTaP/Tdap) 7. Bacillus Calmette-Guerin (BCG) 8. Measles, Mumps and Rubella (MMR) 9. Oral Poliomyelitis vaccine (OPV) 10. Inactivated Poliomyelitis vaccine (IPV) 11. Haemophilus influenzae type b (Hib) 12. Influenza (for patients in high risk groups) 13. Pneumococcal (PPSV23) (for patients in high risk groups) Approved Health Screening 1. Mammogram (for female patients aged 50 and above) For patients below the age of one year old 2. Hearing test 3. G6P deficiency screening 4. Metabolic screening 5. Thyroid function test

4 Outpatient Flexi-Medisave $200 per patient per year Only the patient s Medisave or the patient s spouse s Medisave may be used. Note: Both the patient and the spouse need to be 65 years old or older. * Your non-immediate family members Medisave may be used for these outpatient treatments at restructured hospitals/ medical clinics, subject to eligibility conditions. For example, the patient must be a dependant of the Medisave Account holder who is still actively making contributions, and the patient has exhausted his own and his immediate family members Medisave Accounts. The same prevailing withdrawal limits apply. If you wish to find out if you are eligible to use your non-immediate family member's Medisave (for example, siblings) to pay for subsidised approved outpatient treatments at a restructured hospital or government polyclinics, you need to approach the staff at the hospital s Business Office or the polyclinic. High-risk Groups The definition of high-risk groups for influenza and pneumococcal vaccinations is as follows: Vaccination Schedule Influenza One dose recommended annually Pneumococcal (polysaccharide) One dose of 23-valent pneumococcal polysaccharide vaccine (PPSV23) is recommended. One-time revaccination after 5 years is recommended for (i) persons aged 2 64, with certain medical conditions 1, (ii) persons aged >65 if they were Recommended Groups Persons aged 65 years and older; Children aged six months to less than five years (i.e. 59 months); Adults and children who have chronic disorders of the lung or heart systems, including asthma; Adults and children who have required regular medical follow-up or hospitalisation during the preceding year due to chronic metabolic diseases (including diabetes mellitus), renal, neurologic, liver, or blood disorders, or immunosuppression (including immunosuppression caused by medications or the Human Immunodeficiency Virus); Children and adolescents aged six months to 18 years who are receiving long-term aspirin therapy and therefore might be at risk for developing Reye syndrome after influenza infection; Women at all stages of pregnancy; Residents of nursing homes and intermediate and long-term care facilities. Persons aged 65 years and above Persons aged 2 64 years with the following conditions: Chronic lung disease a, chronic heart disease b, chronic renal disease c, chronic liver disease d, diabetes mellitus; Cochlear implants; Cerebrospinal fluid leaks; Persons with chronic blood disorders Persons with poor immune status/function e.

5 vaccinated five or more years previously and they were <65 years old at time of first vaccination. 1 Chronic renal failure or nephrotic syndrome; functional or anatomic asplenia (e.g., sickle cell disease or splenectomy); and for persons with poor immune status/function. a Including chronic obstructive pulmonary disease (COPD), chronic bronchitis and emphysema; and conditions such as bronchiectasis, cystic fibrosis, interstitial lung fibrosis, pneumoconiosis and bronchopulmonary dysplasia (BPD). Children with respiratory conditions caused by aspiration, or a neuromuscular disease (e.g. cerebral palsy) with a risk of aspiration. b Including those requiring regular medication and/or follow-up for ischaemic heart disease, congenital heart disease, hypertension with heart complications, and chronic heart failure c Including nephrotic syndrome, chronic renal failure and renal transplantation d Including biliary atresia, cirrhosis and chronic hepatitis e Immunosuppression, due to disease or treatment, including HIV infection at all stages,asplenia or splenic dysfunction, patients undergoing chemotherapy leading to immunosuppression, individuals on or likely to be on systemic steroids for more than a month at a dose equivalent to prednisolone at 20mg per day (any age), or for children under 20kg, a dose of 1mg per kg per day Information is correct as at 1 August 2016.